| GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland H Kouros-Mehr, EM Slorach, MD Sternlicht, Z Werb Cell 127 (5), 1041-1055, 2006 | 567 | 2006 |
| Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ... Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003 | 510 | 2003 |
| GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model H Kouros-Mehr, SK Bechis, EM Slorach, LE Littlepage, M Egeblad, ... Cancer cell 13 (2), 141-152, 2008 | 318 | 2008 |
| Hormonal and local control of mammary branching morphogenesis MD Sternlicht, H Kouros-Mehr, P Lu, Z Werb Differentiation 74 (7), 365-381, 2006 | 288 | 2006 |
| Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin MD Sternlicht, SW Sunnarborg, H Kouros-Mehr, Y Yu, DC Lee, Z Werb Development 132 (17), 3923-3933, 2005 | 280 | 2005 |
| Candidate regulators of mammary branching morphogenesis identified by genome‐wide transcript analysis H Kouros‐Mehr, Z Werb Developmental dynamics: an official publication of the American Association …, 2006 | 204 | 2006 |
| Genomic characterization of the human heterotrimeric G protein α, β, and γ subunit genes EH Hurowitz, JM Melnyk, YJ Chen, H Kouros-Mehr, MI Simon, H Shizuya DNA research 7 (2), 111-120, 2000 | 189 | 2000 |
| Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel KJ Bussey, K Chin, S Lababidi, M Reimers, WC Reinhold, WL Kuo, ... Molecular cancer therapeutics 5 (4), 853-867, 2006 | 161 | 2006 |
| GATA-3 and the regulation of the mammary luminal cell fate H Kouros-Mehr, J Kim, SK Bechis, Z Werb Current opinion in cell biology 20 (2), 164-170, 2008 | 134 | 2008 |
| Identification of druggable cancer driver genes amplified across TCGA datasets Y Chen, J McGee, X Chen, TN Doman, X Gong, Y Zhang, N Hamm, X Ma, ... PloS one 9 (5), e98293, 2014 | 100 | 2014 |
| Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale A Bagri, H Kouros-Mehr, KG Leong, GD Plowman Trends in molecular medicine 16 (3), 122-132, 2010 | 97 | 2010 |
| The development and applications of the bacterial artificial chromosome cloning system H Shizuya, H Kouros-Mehr The Keio journal of medicine 50 (1), 26-30, 2001 | 86 | 2001 |
| Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping WC Reinhold, H Kouros-Mehr, KW Kohn, AK Maunakea, S Lababidi, ... Cancer research 63 (5), 1000-1011, 2003 | 71 | 2003 |
| Identification of non-functional human VNO receptor genes provides evidence for vestigiality of the human VNO H Kouros-Mehr, S Pintchovski, J Melnyk, YJ Chen, C Friedman, B Trask, ... Chemical senses 26 (9), 1167-1174, 2001 | 62 | 2001 |
| Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells WC Reinhold, MA Reimers, AK Maunakea, S Kim, S Lababidi, U Scherf, ... Molecular cancer therapeutics 6 (2), 391-403, 2007 | 49 | 2007 |
| The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression LE Littlepage, AS Adler, H Kouros-Mehr, G Huang, J Chou, SR Krig, ... Cancer discovery 2 (7), 638-651, 2012 | 45 | 2012 |
| AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies SM Major, S Nishizuka, D Morita, R Rowland, M Sunshine, ... BMC bioinformatics 7 (1), 192, 2006 | 39 | 2006 |
| Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model C Franci, J Zhou, Z Jiang, Z Modrusan, Z Good, E Jackson, ... PLoS One 8 (3), e58183, 2013 | 36 | 2013 |
| The bioinformatics of microarray gene expression profiling JN Weinstein, U Scherf, JK Lee, S Nishizuka, F Gwadry, AK Bussey, ... Cytometry: The Journal of the International Society for Analytical Cytology …, 2002 | 33 | 2002 |
| MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene YW Phua, A Nguyen, DL Roden, B Elsworth, N Deng, I Nikolic, J Yang, ... Breast Cancer Research 17 (1), 83, 2015 | 31 | 2015 |
